Registered entities
Intezyne Technologies, Inc.
Reg. No. 201253022United States
Investor mix
6 investors on record; lead investors include Gaston Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 2 | 33% |
| Other / undisclosed | 3 | 50% |
Clinical-stage company developing drugs for the treatment of various tumor diseases
6 investors on record; lead investors include Gaston Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 2 | 33% |
| Other / undisclosed | 3 | 50% |